A Phase II Study of the MDR Inhibitor Biricodar (INCEL, VX-710) and Paclitaxel in Women with Advanced Ovarian Cancer Refractory to Paclitaxel Therapy
2002 · Gynecologic Oncology · 98 citations
https://doi.org/10.1006/gyno.2002.6762
S
Susan Campos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Susan Campos is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat